drugset / Trial / NCT00261508

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)

NCT00261508

Phase 3 Completed 80 enrolled Janssen-Ortho Inc., Canada
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the effectiveness of an oral solution of risperidone (an antipsychotic medication) versus placebo in the treatment of behavioral symptoms in children with Pervasive Developmental Disorders (PDD).

Timeline

Start
1999-08
Primary completion
Completion
2001-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified 0.06 mg/kg Oral